Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp | 1,000,000 | reported | 01 Mar 2026 | tx 2+1,500,000 |
| DiaMedica Therapeutics Inc. | 250,000 | reported | 01 Jun 2025 | tx 6+1,047,114 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2026 | PURCHASE | NEUROONE MEDICAL TECHNOLOGIES Corp | 1,000,000 | 0.67 USD | first after silence |
| 01 Mar 2026 | GRANT_AWARD | NEUROONE MEDICAL TECHNOLOGIES Corp | 500,000 | 0.00 USD | deriv |
| 01 Jun 2025 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 250,000 | 0.00 USD | deriv |
| 01 Jun 2024 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 130,000 | 0.00 USD | deriv |
| 16 Nov 2023 | PURCHASE | DiaMedica Therapeutics Inc. | 20,000 | 2.46 USD | |
| 23 Jun 2023 | PURCHASE | DiaMedica Therapeutics Inc. | 38,364 | 3.91 USD | |
| 10 Apr 2023 | PURCHASE | DiaMedica Therapeutics Inc. | 468,750 | 1.60 USD | |
| 10 Apr 2023 | GRANT_AWARD | DiaMedica Therapeutics Inc. | 140,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 01 Mar 2026.